Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access ProgramRoberta Roberti, Simona Lattanzi, Giovanni Assenza et al.|Epilepsia|2024Cited by 28
Brivaracetam as add‐on treatment in focal epilepsy: A real‐world time‐based analysisSimona Lattanzi, Filippo Dainese, Giovanni De Maria et al.|Epilepsia|2020Cited by 18
Effectiveness and safety of adjunctive cenobamate in people with focal‐onset epilepsy: Interim results after 24‐week observational period from the <scp>BLESS</scp> studySimona Lattanzi, Gabriele Camattari, Fedele Dono et al.|Epilepsia|2025Cited by 18
Diagnostic Yield and Cost-Effectiveness of “Dynamic” Exome Analysis in Epilepsy with Neurodevelopmental Disorders: A Tertiary-Center Experience in Northern ItalyCostanza Varesio, Valentina De Giorgis, Marialuisa Valente et al.|Diagnostics|2021Cited by 9